We began publishing BioTuesdays in 2009 to cover small and medium-sized healthcare company news often overlooked by traditional media. We profile companies with innovative technologies and compelling investment stories that may otherwise go unrecognized. BioTuesdays also publishes numerous briefs, reporting the pharma and biotech industry’s pipeline developments, executive moves and views from the Street.

BioTuesdays is published by Kilmer Lucas, one of North America’s leading healthcare-only investor relations firms. Kilmer Lucas employs a unique “outsourced in-house” partnership model, taking a holistic approach to building customized IR strategies. Kilmer Lucas leverages its longstanding relationships and strong track record to positively influence investor perceptions, maximize stock valuations and lower the cost of capital needed to fund clients’ growth.